Literature DB >> 233660

Effect of parathyroid hormone on plasma prolactin in man.

R Isaac, R E Merceron, G Caillens, J P Raymond, R Ardaillou.   

Abstract

The iv infusion of parathyroid extract or the synthetic fragments of 1-34 bovine or human parathyroid hormone produced a rapid and marked increase of plasma PRL in normal subjects. The stimulation of the release of endogenous parathyroid hormone by administration of disodium EDTA also resulted in a parallel increase of plasma PRL. Parathyroid hormone did not act via plasma cAMP, as the plasma level reached by this nucleotide was too small to produce PRL release. The ingestion of L-dopa 2 h before parathyroid hormone infusion suppressed the PRL response, suggesting that dopamine and parathyroid hormone interact at a common site. As it has been recently shown that PRL stimulates the renal synthesis of 1,25-dihydroxycholecalciferol, the present data suggest that the effect of parathyroid hormone on this synthesis may be due to the increase in plasma PRL.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 233660     DOI: 10.1210/jcem-47-1-18

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

1.  A simplified diagnostic test in hypoparathyroidism and pseudohypoparathyroidism type I with synthetic 1-38 fragment of human parathyroid hormone.

Authors:  K Kruse; U Kracht
Journal:  Eur J Pediatr       Date:  1987-07       Impact factor: 3.183

Review 2.  Gonadal dysfunction in chronic kidney disease.

Authors:  Biff F Palmer; Deborah J Clegg
Journal:  Rev Endocr Metab Disord       Date:  2017-03       Impact factor: 6.514

Review 3.  Drug-induced changes in prolactin secretion. Clinical implications.

Authors:  K Hell; H Wernze
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Nov-Dec

4.  Does calcitonin modulate anterior pituitary hormone secretion?

Authors:  G P Ceda; G Valenti; E Dall'Aglio; E Palummeri; D Provvedini; U Butturini
Journal:  J Endocrinol Invest       Date:  1982 Sep-Oct       Impact factor: 4.256

5.  Prolactin secretion in kidney transplant patients.

Authors:  W Grzeszczak; F Kokot; A Wiecek; E Zukowska-Szczechowska
Journal:  Int Urol Nephrol       Date:  1990       Impact factor: 2.370

Review 6.  Chronic kidney disease and erectile dysfunction.

Authors:  Etsu Suzuki; Hiroaki Nishimatsu; Shigeyoshi Oba; Masao Takahashi; Yukio Homma
Journal:  World J Nephrol       Date:  2014-11-06

7.  Effects of L-dopa on plasma levels of parathyroid hormone in calves.

Authors:  J W Blum; D Schams; W Born; M Da Prada
Journal:  J Endocrinol Invest       Date:  1982 Sep-Oct       Impact factor: 4.256

8.  Effect of 1,25-dihydroxyvitamin D3 on plasma prolactin in patients with renal failure on regular dialysis treatment.

Authors:  D Verbeelen; L Vanhaelst; A C Van Steirteghem; J Sennesael
Journal:  J Endocrinol Invest       Date:  1983-10       Impact factor: 4.256

9.  Prolactin and calcium metabolism: influence of hyperprolactinemia on immunoreactive parathyroid hormone levels in man and in the rat.

Authors:  C E Fiore; R D'Agata; G Clementi; L S Malatino
Journal:  J Endocrinol Invest       Date:  1984-12       Impact factor: 4.256

10.  Effect of 1,25-dihydroxyvitamin D3 and nifedipine on prolactin release in normal man.

Authors:  D Verbeelen; L Vanhaelst; M Fuss; A C Van Steirteghem
Journal:  J Endocrinol Invest       Date:  1985-04       Impact factor: 4.256

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.